Processa Pharmaceuticals (PCSA) Quick Ratio: History & Chart

Processa Pharmaceuticals, Inc.(PCSA)

Biotechnology · Vero Beach, FL

$1.49-0.00 (-0.34%)

Delayed quote: Oct 6, 2026, 3:27 PM EDT

About Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States. The company's leading investigational drug, PCS499, is an oral tablet presently undergoing Phase 2B clinical assessment. It aims to treat both ulcerative and non-ulcerative manifestations of necrobiosis lipoidica, a chronic and disfiguring dermatological condition. Processa's portfolio also features PCS12852, a unique selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist. This compound is currently in Phase 2A clinical trials for its potential application in managing gastroparesis, chronic constipation, constipation-predominant irritable bowel syndrome, and functional dyspepsia. Furthermore, the firm is advancing PCS3117, a cytosine analog, which has reached Phase 2B clinical trials for its use in pancreatic cancer and non-small cell lung cancer. Another candidate, PCS6422, an oral, potent, selective, and irreversible inhibitor of dihydropyrimidine dehydrogenase, is progressing through Phase 1B clinical trials for metastatic colorectal and breast cancers. In addition, Processa is developing PCS11T, an analog derived from the drugs SN38 and irinotecan, intended for the treatment of diverse cancer types. The company was founded in 2011 and maintains its corporate headquarters in Hanover, Maryland.

Vero Beach, FL

12 employees

www.processapharmaceuticals.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: George K. Ng

View full financials

PCSA Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

0.87

QUICK RATIO (ACID-TEST) AVG TTM

2.32

QUICK RATIO (ACID-TEST) AVG 3Y

4.89

QUICK RATIO (ACID-TEST) AVG 5Y

7.34

QUICK RATIO (ACID-TEST) AVG 10Y

5.06

QUICK RATIO (ACID-TEST) AVG 15Y

2.68

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

-62.65%

CURRENT VS 3Y AVG

-82.29%

CURRENT VS 5Y AVG

-88.21%

CURRENT VS 10Y AVG

-82.88%

CURRENT VS 15Y AVG

-67.69%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.35

median of 871 covered companies

CURRENT VS SECTOR MEDIAN

-74.16%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Processa Pharmaceuticals, Inc. (PCSA)	$4.11M	0.87	2.32	4.89	7.34
GRI Bio, Inc. (GRI)vs ›	$4.13M	10.30	3.34	1.98	1.38
Aptevo Therapeutics Inc. (APVO)vs ›	$3.97M	2.08	2.77	2.83	2.68
CollPlant Biotechnologies Ltd. (CLGN)vs ›	$4.27M	1.35	3.30	6.18	6.77
20/20 Biolabs Inc. (AIDX)vs ›	$4.44M	1.95	2.83	3.75	3.40
60 Degrees Pharmaceuticals, Inc. (SXTP)vs ›	$3.85M	1.78	2.64	1.92	1.57
Dermata Therapeutics, Inc. (DRMA)vs ›	$4.55M	2.73	3.29	4.75	4.47
Evogene Ltd. (EVGN)vs ›	$3.62M	3.54	2.77	4.28	5.12
Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs ›	$3.74M	3.73	3.25	4.33	4.33
Ernexa Therapeutics Inc. (ERNA)vs ›	$3.61M	2.01	0.91	1.26	1.78

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Processa Pharmaceuticals, Inc. (PCSA)

$4.11M

0.87

2.32

4.89

7.34

GRI Bio, Inc. (GRI)vs ›

$4.13M

10.30

3.34

1.98

1.38

Aptevo Therapeutics Inc. (APVO)vs ›

$3.97M

2.08

2.77

2.83

2.68

CollPlant Biotechnologies Ltd. (CLGN)vs ›

$4.27M

1.35

3.30

6.18

6.77

20/20 Biolabs Inc. (AIDX)vs ›

$4.44M

1.95

2.83

3.75

3.40

60 Degrees Pharmaceuticals, Inc. (SXTP)vs ›

$3.85M

1.78

2.64

1.92

1.57

Dermata Therapeutics, Inc. (DRMA)vs ›

$4.55M

2.73

3.29

4.75

4.47

Evogene Ltd. (EVGN)vs ›

$3.62M

3.54

2.77

4.28

5.12

Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs ›

$3.74M

3.73

3.25

4.33

Ernexa Therapeutics Inc. (ERNA)vs ›

$3.61M

2.01

0.91

1.26

1.78

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Processa Pharmaceuticals, Inc. (PCSA)?

The quick ratio (acid-test) for PCSA stock is 0.87.

Is Processa Pharmaceuticals, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 0.87 is 88% below its 5-year average of 7.34, near the low end of its 5-year range (0.87–19.43).

What is the TTM average quick ratio (acid-test) for Processa Pharmaceuticals, Inc. (PCSA)?

The TTM average quick ratio (acid-test) for PCSA stock is 2.32.

What is the 3Y average quick ratio (acid-test) for Processa Pharmaceuticals, Inc. (PCSA)?

The 3Y average quick ratio (acid-test) for PCSA stock is 4.89.

What is the 5Y average quick ratio (acid-test) for Processa Pharmaceuticals, Inc. (PCSA)?

The 5Y average quick ratio (acid-test) for PCSA stock is 7.34.

What is the 10Y average quick ratio (acid-test) for Processa Pharmaceuticals, Inc. (PCSA)?

The 10Y average quick ratio (acid-test) for PCSA stock is 5.06.

What is the 15Y average quick ratio (acid-test) for Processa Pharmaceuticals, Inc. (PCSA)?

The 15Y average quick ratio (acid-test) for PCSA stock is 2.68.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	0.87
2026-03-31	0.98
2025-12-31	2.54
2025-09-30	3.76
2025-06-30	3.45
2025-03-31	2.93
2024-12-31	1.22
2024-09-30	3.97
2024-06-30	4.82
2024-03-31	9.70
2023-12-31	7.71
2023-09-30	9.57
2023-06-30	12.05
2023-03-31	5.65
2022-12-31	8.40
2022-09-30	9.13
2022-06-30	8.89
2022-03-31	15.49
2021-12-31	18.87
2021-09-30	16.85
2021-06-30	19.43
2021-03-31	22.40
2020-12-31	13.27
2020-09-30	0.14
2020-06-30	0.30
2020-03-31	0.29
2019-12-31	0.85
2019-09-30	2.49
2019-06-30	1.26
2019-03-31	2.13
2018-12-31	3.13
2018-09-30	4.05
2018-06-30	5.53
2018-03-31	0.65
2017-12-31	1.14
2017-09-30	0.70
2017-06-30	0.00
2017-03-31	0.00
2016-12-31	0.00
2016-09-30	0.02
2016-06-30	0.02
2016-03-31	0.02
2015-12-31	0.05
2015-09-30	0.07
2015-06-30	0.07
2015-03-31	0.10
2014-12-31	0.19
2014-09-30	0.25
2014-06-30	0.46
2014-03-31	0.27
2013-12-31	0.26
2013-09-30	0.84
2013-06-30	0.31
2013-03-31	0.45
2012-12-31	1.55
2012-09-30	8.22
2012-06-30	0.00
2012-03-31	0.00
2011-12-31	0.00

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

0.87

2026-03-31

0.98

2025-12-31

2.54

2025-09-30

3.76

2025-06-30

3.45

2025-03-31

2.93

2024-12-31

1.22

2024-09-30

3.97

2024-06-30

4.82

2024-03-31

9.70

2023-12-31

7.71

2023-09-30

9.57

2023-06-30

12.05

2023-03-31

5.65

2022-12-31

8.40

2022-09-30

9.13

2022-06-30

8.89

2022-03-31

15.49

2021-12-31

18.87

2021-09-30

16.85

2021-06-30

19.43

2021-03-31

22.40

2020-12-31

13.27

2020-09-30

0.14

2020-06-30

0.30

2020-03-31

0.29

2019-12-31

0.85

2019-09-30

2.49

2019-06-30

1.26

2019-03-31

2.13

2018-12-31

3.13

2018-09-30

4.05

2018-06-30

5.53

2018-03-31

0.65

2017-12-31

1.14

2017-09-30

0.70

2017-06-30

0.00

2017-03-31

0.00

2016-12-31

0.00

2016-09-30

0.02

2016-06-30

0.02

2016-03-31

0.02

2015-12-31

0.05

2015-09-30

0.07

2015-06-30

0.07

2015-03-31

0.10

2014-12-31

0.19

2014-09-30

0.25

2014-06-30

0.46

2014-03-31

0.27

2013-12-31

0.26

2013-09-30

0.84

2013-06-30

0.31

2013-03-31

0.45

2012-12-31

1.55

2012-09-30

8.22

2012-06-30

0.00

2012-03-31

0.00

2011-12-31

0.00

Quick Ratio (Acid-Test): 0.87

PCSA Quick Ratio

PCSA Average Quick Ratio (Acid-Test) Chart

PCSA Current vs Average Quick Ratio (Acid-Test) Chart

PCSA Quick Ratio (Acid-Test) Metrics

PCSA Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

PCSA Quick Ratio (Acid-Test) History

Related Metrics